Cargando…
Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells
Metabolic alteration is characteristic during tumour growth and therapy; however, targeting metabolic rewiring could overcome therapy resistance. mTOR hyperactivity, autophagy and other metabolic processes, including mitochondrial functions, could be targeted in breast cancer progression. We investi...
Autores principales: | Dankó, Titanilla, Petővári, Gábor, Sztankovics, Dániel, Moldvai, Dorottya, Raffay, Regina, Lőrincz, Péter, Visnovitz, Tamás, Zsiros, Viktória, Barna, Gábor, Márk, Ágnes, Krencz, Ildikó, Sebestyén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347279/ https://www.ncbi.nlm.nih.gov/pubmed/34360785 http://dx.doi.org/10.3390/ijms22158019 |
Ejemplares similares
-
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
por: Sebestyén, Anna, et al.
Publicado: (2022) -
3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures
por: Sztankovics, Dániel, et al.
Publicado: (2023) -
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
por: Dankó, Titanilla, et al.
Publicado: (2022) -
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
por: Krencz, Ildikó, et al.
Publicado: (2022) -
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
por: Petővári, Gábor, et al.
Publicado: (2018)